BELITE BIO, INC (BLTE)
↓ Download CSVKey ratios (FY2025)
-10.1%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Income | -$84.21M | -$40.00M | -$31.67M | -$12.82M | -$9.80M | -$5.74M | — |
| Net Income | -$77.61M | -$36.14M | -$31.63M | -$12.65M | -$9.67M | -$5.75M | — |
| EPS (Diluted) | $-2.31 | $-1.18 | $-1.19 | $-0.63 | $-1.01 | $-0.65 | — |
| Total Assets | $780.56M | $152.13M | $94.64M | $44.27M | $18.35M | — | — |
| Total Liabilities | $10.07M | $6.31M | $4.21M | $2.77M | $1.64M | — | — |
| Shareholders' Equity | $770.49M | $145.82M | $90.43M | $41.50M | -$15.09M | -$7.04M | -$3.74M |
| Cash & Equivalents | $352.93M | $31.68M | $88.16M | $42.09M | $17.34M | — | — |
| Operating Cash Flow | -$36.99M | -$29.23M | -$29.84M | -$11.46M | -$7.47M | -$4.44M | — |
| Capital Expenditures | $71.0K | $116.0K | $63.0K | $394.0K | $74.0K | — | — |
| Shares Outstanding | 33.54M | 30.54M | 26.59M | 19.98M | 9.57M | 8.79M | — |